3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Acute Hyperinsulinemia Alters Bone Turnover in Women and Men With Type 1 Diabetes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Type 1 diabetes (T1D) increases fracture risk across the lifespan. The low bone turnover associated with T1D is thought to be related to glycemic control, but it is unclear whether peripheral hyperinsulinemia due to dependence on exogenous insulin has an independent effect on suppressing bone turnover. The purpose of this study was to test the bone turnover marker (BTM) response to acute hyperinsulinemia. Fifty‐eight adults aged 18 to 65 years with T1D over 2 years were enrolled at seven T1D Exchange Clinic Network sites. Participants had T1D diagnosis between age 6 months to 45 years. Participants were stratified based on their residual endogenous insulin secretion measured as peak C‐peptide response to a mixed meal tolerance test. BTMs (CTX, P1NP, sclerostin [SCL], osteonectin [ON], alkaline phosphatase [ALP], osteocalcin [OCN], osteoprotegerin [OPG], osteopontin [OPN], and IGF‐1) were assessed before and at the end of a 2‐hour hyperinsulinemic‐euglycemic clamp (HEC). Baseline ON ( r = −0.30, p = .022) and OCN ( r = −0.41, p = .002) were negatively correlated with age at T1D diagnosis, but baseline BTMs were not associated with HbA1c. During the HEC, P1NP decreased significantly (−14.5 ± 44.3%; p = .020) from baseline. OCN, ON, and IGF‐1 all significantly increased (16.0 ± 13.1%, 29.7 ± 31.7%, 34.1 ± 71.2%, respectively; all p < .001) during the clamp. The increase in SCL was not significant (7.3 ± 32.9%, p = .098), but the decrease in CTX (−12.4 ± 48.9, p = .058) neared significance. ALP and OPG were not changed from baseline ( p = .23 and p = .77, respectively). Baseline ON and SCL were higher in men, but OPG was higher in women (all p ≤ .029). SCL was the only BTM that changed differently in women than men. There were no differences in baseline BTMs or change in BTMs between C‐peptide groups. Exogenous hyperinsulinemia acutely alters bone turnover, suggesting a need to determine whether strategies to promote healthy remodeling may protect bone quality in T1D. © 2020 American Society for Bone and Mineral Research © 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.

          The osteoblast-specific secreted molecule osteocalcin behaves as a hormone regulating glucose metabolism and fat mass in two mutant mouse strains. Here, we ask two questions: is the action of osteocalcin on beta cells and adipocytes elicited by the same concentrations of the molecule, and more importantly, does osteocalcin regulate energy metabolism in WT mice? Cell-based assays using isolated pancreatic islets, a beta cell line, and primary adipocytes showed that picomolar amounts of osteocalcin are sufficient to regulate the expression of the insulin genes and beta cell proliferation markers, whereas nanomolar amounts affect adiponectin and Pgc1alpha expression in white and brown adipocytes, respectively. In vivo the same difference exists in osteocalcin's ability to regulate glucose metabolism on the one hand and affect insulin sensitivity and fat mass on the other hand. Furthermore, we show that long-term treatment of WT mice with osteocalcin can significantly weaken the deleterious effect on body mass and glucose metabolism of gold thioglucose-induced hyperphagia and high-fat diet. These results establish in WT mice the importance of this novel molecular player in the regulation of glucose metabolism and fat mass and suggest that osteocalcin may be of value in the treatment of metabolic diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes.

            It is generally accepted that complete β-cell destruction eventually occurs in individuals with type 1 diabetes, which has implications for treatment approaches and insurance coverage. The frequency of residual insulin secretion in a large cohort of individuals at varying ages of diagnosis and type 1 diabetes duration is unknown.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Type 1 diabetes and risk of fracture: meta-analysis and review of the literature.

              To conduct a systematic review and meta-analysis of observational studies in order to assess the association between Type 1 diabetes and fractures.
                Bookmark

                Author and article information

                Contributors
                viral.shah@cuanschutz.edu
                Journal
                JBMR Plus
                JBMR Plus
                10.1002/(ISSN)2473-4039
                JBM4
                JBMR Plus
                John Wiley & Sons, Inc. (Hoboken, USA )
                2473-4039
                03 August 2020
                September 2020
                : 4
                : 9 ( doiID: 10.1002/jbm4.v4.9 )
                : e10389
                Affiliations
                [ 1 ] Department of OrthopedicsSchool of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA
                [ 2 ] Department of Biostatistics and Informatics Colorado School of Public Health University of Colorado Anschutz Medical Campus Aurora CO USA
                [ 3 ] Department of Pediatrics, Section of EndocrinologySchool of Medicine University of Colorado Anschutz Medical Campus Aurora CO USA
                [ 4 ] Barbara Davis Center for Diabetes University of Colorado Anschutz Medical Campus Aurora CO USA
                [ 5 ] Children's Hospital Colorado University of Colorado School of Medicine Aurora CO USA
                [ 6 ] Institute for Diabetes, Obesity & Metabolism University of Pennsylvania Perelman School of Medicine Philadelphia PA USA
                [ 7 ] Jaeb Center for Health Research Tampa FL USA
                [ 8 ] Diabetes Program Benaroya Research Institute Seattle WA USA
                Author notes
                [*] [* ]Address correspondence to: Viral N Shah, MD, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, 1775 Aurora Ct, Room # M20‐1318, Aurora, CO 80045, USA. E‐mail: viral.shah@ 123456cuanschutz.edu
                Author information
                https://orcid.org/0000-0001-6388-8201
                https://orcid.org/0000-0002-3827-7107
                Article
                JBM410389
                10.1002/jbm4.10389
                7507374
                32995692
                bb3fffb1-216b-44a6-82d5-9c9c07ba2a3b
                © 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 20 April 2020
                : 25 June 2020
                : 30 June 2020
                Page count
                Figures: 3, Tables: 5, Pages: 9, Words: 7426
                Funding
                Funded by: Leona M. and Harry B. Helmsley Charitable Trust , open-funder-registry 10.13039/100007028;
                Award ID: 2016PG‐T1D053 Dr. Shah
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                September 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.1 mode:remove_FC converted:22.09.2020

                bone metabolism,hyperinsulinemic‐euglycemic clamp,type 1 diabetes

                Comments

                Comment on this article